231 related articles for article (PubMed ID: 30860846)
1. Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy.
Zang X; Zhang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Mol Pharm; 2019 Apr; 16(4):1714-1722. PubMed ID: 30860846
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy.
Zang X; Zhang X; Hu H; Qiao M; Zhao X; Deng Y; Chen D
Mol Pharm; 2019 May; 16(5):2249-2258. PubMed ID: 30969779
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection.
Huang Z; Gan J; Long Z; Guo G; Shi X; Wang C; Zang Y; Ding Z; Chen J; Zhang J; Dong L
Biomaterials; 2016 Jun; 90():72-84. PubMed ID: 26994345
[TBL] [Abstract][Full Text] [Related]
4. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
Jing Z; Li Y; Song J; Zang X
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
[TBL] [Abstract][Full Text] [Related]
5. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
6. Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy.
Liu L; Yi H; He H; Pan H; Cai L; Ma Y
Biomaterials; 2017 Jul; 134():166-179. PubMed ID: 28463694
[TBL] [Abstract][Full Text] [Related]
7. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
8. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.
Wang Y; Lin YX; Qiao SL; An HW; Ma Y; Qiao ZY; Rajapaksha RP; Wang H
Biomaterials; 2017 Jan; 112():153-163. PubMed ID: 27768970
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
11. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
Wang Y; Luan Z; Zhao C; Bai C; Yang K
Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
[TBL] [Abstract][Full Text] [Related]
12. Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages.
Zhang Y; Wu L; Li Z; Zhang W; Luo F; Chu Y; Chen G
Biomacromolecules; 2018 Jun; 19(6):2098-2108. PubMed ID: 29634251
[TBL] [Abstract][Full Text] [Related]
13. Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.
Li K; Lu L; Xue C; Liu J; He Y; Zhou J; Xia Z; Dai L; Luo Z; Mao Y; Cai K
Nanoscale; 2020 Jan; 12(1):130-144. PubMed ID: 31799577
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Chen D; Xie J; Fiskesund R; Dong W; Liang X; Lv J; Jin X; Liu J; Mo S; Zhang T; Cheng F; Zhou Y; Zhang H; Tang K; Ma J; Liu Y; Huang B
Nat Commun; 2018 Feb; 9(1):873. PubMed ID: 29491374
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration.
Shi C; Liu T; Guo Z; Zhuang R; Zhang X; Chen X
Nano Lett; 2018 Nov; 18(11):7330-7342. PubMed ID: 30339753
[TBL] [Abstract][Full Text] [Related]
16. Improved anti-tumor efficacy of paclitaxel in combination with MicroRNA-125b-based tumor-associated macrophage repolarization in epithelial ovarian cancer.
Parayath NN; Gandham SK; Leslie F; Amiji MM
Cancer Lett; 2019 Oct; 461():1-9. PubMed ID: 31288064
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
[TBL] [Abstract][Full Text] [Related]
18. Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy.
Shen S; Li HJ; Chen KG; Wang YC; Yang XZ; Lian ZX; Du JZ; Wang J
Nano Lett; 2017 Jun; 17(6):3822-3829. PubMed ID: 28488871
[TBL] [Abstract][Full Text] [Related]
19. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
20. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
